These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9149175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Otitis media with effusion: components which contribute to the viscous properties.
    Carrie S, Hutton DA, Birchall JP, Green GG, Pearson JP.
    Acta Otolaryngol; 1992; 112(3):504-11. PubMed ID: 1441992
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Compositional difference in middle ear effusion: mucous versus serous.
    Chung MH, Choi JY, Lee WS, Kim HN, Yoon JH.
    Laryngoscope; 2002 Jan; 112(1):152-5. PubMed ID: 11802055
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor.
    Maxwell K, Leonard G, Kreutzer DL.
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):984-8. PubMed ID: 9305251
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-8 expression in otitis media.
    Maxwell KS, Fitzgerald JE, Burleson JA, Leonard G, Carpenter R, Kreutzer DL.
    Laryngoscope; 1994 Aug; 104(8 Pt 1):989-95. PubMed ID: 8052085
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of interleukin-1beta in a murine model of otitis media with effusion.
    Watanabe T, Hirano T, Suzuki M, Kurono Y, Mogi G.
    Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):574-80. PubMed ID: 11407850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determining otitis media severity from middle ear fluid analysis.
    Juhn SK, Garvis WJ, Lees CJ, Le CT, Kim CS.
    Ann Otol Rhinol Laryngol Suppl; 1994 May; 163():43-5. PubMed ID: 8179269
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proinflammatory and immunoregulatory cytokines in the middle ear effusions.
    Skotnicka B, Hassmann E.
    Int J Pediatr Otorhinolaryngol; 2008 Jan; 72(1):13-7. PubMed ID: 17976828
    [Abstract] [Full Text] [Related]

  • 17. Viral RNA in middle ear mucosa and exudates in patients with chronic otitis media with effusion.
    Moyse E, Lyon M, Cordier G, Mornex JF, Collet L, Froehlich P.
    Arch Otolaryngol Head Neck Surg; 2000 Sep; 126(9):1105-10. PubMed ID: 10979124
    [Abstract] [Full Text] [Related]

  • 18. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC.
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [Abstract] [Full Text] [Related]

  • 19. Immunologic characteristics of cytokines in otitis media with effusion.
    Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A.
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():21-5. PubMed ID: 1416648
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.